InMode (INMD) Depreciation & Amortization (CF) (2024 - 2025)
InMode recorded quarterly Depreciation & Amortization (CF) of $174000.0 in Q4 2025, down 29.84% quarter-over-quarter from $248000.0 in Q4 2024, and down 29.84% year-over-year from $248000.0 in Q4 2024.
InMode's Depreciation & Amortization (CF) history runs 2 years deep, the most recent figure standing at $174000.0 for Q4 2025.
- In Q4 2025, Depreciation & Amortization (CF) fell 29.84% year-over-year to $174000.0; the TTM figure through Mar 2026 stood at $174000.0 (down 29.84% YoY), while the FY2025 annual figure was $695000.0, down 4.53% from the prior year.
- Depreciation & Amortization (CF) came in at $174000.0 for Q4 2025 at InMode, down from $248000.0 in the prior quarter.
- In the past five years, Depreciation & Amortization (CF) ranged from a high of $248000.0 in Q4 2024 to a low of $174000.0 in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 381.00 Mn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 120.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 749.00 Mn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 351.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 40.90 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 67.10 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 78.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 123.40 Mn |
| 10 | InMode | 3.41 | -384.57 Mn | 61.55 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 174,000.00 |
| Dec 31, 2025 | 174,000.00 |
| Dec 31, 2024 | 248,000.00 |
| Dec 31, 2024 | 248,000.00 |